Inactive Instrument

Imaging3, Inc. Stock OTC Bulletin Board

US45248F1030

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

22-11-18	Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-09-29	Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc	CI

Grapefruit USA, Inc. is engaged in the development of its patented Hourglass Time Release Tetrahydrocannabinol (THC)+Cannabinoid (CBD)-Infused Topical Cream. Its Hourglass is the patented Full Spectrum THC+ CBD Topical delivery Cream that provides its users with a full body, synergistic entourage effect. Hourglass is available in licensed retail and mobile cannabis dispensaries in Central California and Los Angeles County, California, the United States of America. Its certified organic CBD tincture stimulates health, wellness and well-being with its organic, Keto friendly, MCT Oil. Its certified organic pet CBD tincture is a hemp-derived CBD oil made with 100% certified organic extra virgin olive oil. The Company is also engaged in retail and wholesale sales of its Summit Boys branded products in California.

Employees

Sector

Pharmaceuticals

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	6.27M 5.39M 5.07M 4.64M 8.67M 592M 8.7M 59.96M 23.27M 304M 23.54M 23.02M 978M	P/E 2020	-8.5x	P/E 2021	-1.78x
Enterprise Value	11.89M 10.23M 9.63M 8.79M 16.45M 1.12B 16.49M 114M 44.14M 576M 44.65M 43.67M 1.86B	EV / Sales 2020	13x	EV / Sales 2021	27.5x
Free-Float	60.53%	Yield 2020 *	-	Yield 2021	-

22-11-18	Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-09-29	Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc	CI
22-08-22	Grapefruit USA, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
22-05-20	Grapefruit USA, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-04-25	California Department of Cannabis Control Renews Grapefruit USA's California Cannabis Distributor License by May 13, 2023	CI
22-04-19	Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass Time Release THC+CBD Delivery Cream	CI
22-04-15	Grapefruit USA, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
22-04-14	Grapefruit USA, Inc. Auditor Raises 'Going Concern' Doubt	CI
22-04-04	Grapefruit’S Summit Boys Brand Goes Mobile on Blitzdirect.com	CI
22-03-27	Grapefruit USA, Inc. signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc.	CI
22-03-03	Grapefruit USA, Inc. Updates on Hourglass Health Canada NNCP Submission	CI
22-02-23	Grapefruit Usa, Inc. Announces CEO Bradley J. Yourist Has Been Elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’S Property Owners Association Board of Directors	CI
21-12-06	Grapefruit USA Announce Official Launch of Patented Time-Release, Hemp-Based CBD Topical Cream with Boosted Bioavailability, Made Possible by Its Proprietary Hourglass? Technology	CI

23-03-10	Grapefruit USA, Inc. Provides Further Update on Diagnostic Lab Corporation Acquisition, Securing New Financing and Retail Store Plan	AQ
22-12-21	GRAPEFRUIT USA, INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
22-11-21	Grapefruit USA, Inc. Provides Further Update on Diagnostic Lab Corporation, Inc. Acquisition, Securing New Financing	AQ
22-11-18	GRAPEFRUIT USA, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
22-10-20	GRAPEFRUIT USA, INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)	AQ

Manager	Title	Age	Since
Bradley Yourist CEO	Chief Executive Officer	56	-
Craig Tarnutze DFI	Director of Finance/CFO	-	-
Daniel Yourist COO	Chief Operating Officer	56	-

Director	Title	Age	Since
James Jordan BRD	Director/Board Member	-	2020-01-21
Bradley Yourist BRD	Director/Board Member	56	-
Daniel Yourist BRD	Director/Board Member	56	-

Imaging3, Inc. Stock OTC Bulletin Board

Stocks

US45248F1030

Pharmaceuticals

Valuation : Imaging3, Inc.

Latest news : Imaging3, Inc.

Press Releases : Imaging3, Inc.

Managers and Directors : Imaging3, Inc.

Other Pharmaceuticals

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.88%	-2.15%	+58.05%	+105.91%	1,024B
JOHNSON & JOHNSON	-1.15%	+2.68%	+54.25%	+71.29%	663B
ABBVIE INC.	-1.44%	+0.38%	+20.65%	+75.54%	453B
ROCHE HOLDING AG	+0.14%	-0.47%	+30.20%	+40.61%	352B
NOVARTIS AG	-1.33%	+4.72%	+24.62%	+47.60%	304B
ASTRAZENECA PLC	-1.15%	+0.30%	-0.69%	+11.83%	252B
AMGEN INC.	-1.55%	+1.11%	+54.15%	+72.13%	236B
NOVO NORDISK A/S	-0.88%	+1.15%	-14.60%	-54.84%	206B
GILEAD SCIENCES, INC.	-0.15%	+3.65%	+31.24%	+100.90%	187B
Average	-0.93%	+1.09%	+28.65%	+52.33%	408.71B
Weighted average by Cap.	-0.96%	+0.55%	+37.63%	+67.00%

	2020	2021
Net sales	3.67M 3.16M 2.97M 2.72M 5.08M 347M 5.09M 35.13M 13.63M 178M 13.79M 13.49M 573M	589K 507K 477K 436K 815K 55.61M 817K 5.63M 2.19M 28.53M 2.21M 2.16M 91.91M
Net income	-4.06M -3.49M -3.28M -3M -5.61M -383M -5.63M -38.81M -15.06M -197M -15.23M -14.9M -633M	-5.5M -4.74M -4.46M -4.07M -7.62M -520M -7.64M -52.66M -20.44M -267M -20.67M -20.22M -859M
Net Debt	4.74M 4.08M 3.84M 3.51M 6.56M 448M 6.58M 45.38M 17.61M 230M 17.81M 17.42M 740M	5.62M 4.84M 4.55M 4.16M 7.78M 531M 7.8M 53.78M 20.87M 272M 21.11M 20.65M 877M